This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Topiramate

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20230928

Version

3

Spl Product Data Elements

Topiramate Topiramate TOPIRAMATE TOPIRAMATE ETHYLCELLULOSE (10 MPA.S) ETHYLCELLULOSE (45 MPA.S) FERRIC OXIDE RED FERROSOFERRIC OXIDE HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED HYPROMELLOSE 2910 (15 MPA.S) HYPROMELLOSE 2910 (6 MPA.S) MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL 3350 POLYETHYLENE GLYCOL 400 POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC TALC TITANIUM DIOXIDE TRIETHYL CITRATE WATER FLESH OPAQUE CAP WHITE OPAQUE BODY CAPSULE 1039 Topiramate Topiramate TOPIRAMATE TOPIRAMATE ETHYLCELLULOSE (10 MPA.S) ETHYLCELLULOSE (45 MPA.S) FERRIC OXIDE YELLOW FERROSOFERRIC OXIDE HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED HYPROMELLOSE 2910 (15 MPA.S) HYPROMELLOSE 2910 (6 MPA.S) MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL 3350 POLYETHYLENE GLYCOL 400 POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC TALC TITANIUM DIOXIDE TRIETHYL CITRATE WATER IVORY OPAQUE CAP WHITE OPAQUE BODY CAPSULE 1040 Topiramate Topiramate TOPIRAMATE TOPIRAMATE ETHYLCELLULOSE (10 MPA.S) ETHYLCELLULOSE (45 MPA.S) FERRIC OXIDE RED FERRIC OXIDE YELLOW FERROSOFERRIC OXIDE HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED HYPROMELLOSE 2910 (15 MPA.S) HYPROMELLOSE 2910 (6 MPA.S) MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL 3350 POLYETHYLENE GLYCOL 400 POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC TALC TITANIUM DIOXIDE TRIETHYL CITRATE WATER MEDIUM ORANGE OPAQUE CAP WHITE OPAQUE BODY CAPSULE 1041 Topiramate Topiramate TOPIRAMATE TOPIRAMATE ETHYLCELLULOSE (10 MPA.S) ETHYLCELLULOSE (45 MPA.S) FERROSOFERRIC OXIDE HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED HYPROMELLOSE 2910 (15 MPA.S) HYPROMELLOSE 2910 (6 MPA.S) MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL 3350 POLYETHYLENE GLYCOL 400 POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC TALC TITANIUM DIOXIDE TRIETHYL CITRATE WATER WHITE OPAQUE CAP WHITE OPAQUE BODY CAPSULE 1042 Topiramate Topiramate TOPIRAMATE TOPIRAMATE ETHYLCELLULOSE (10 MPA.S) ETHYLCELLULOSE (45 MPA.S) FERRIC OXIDE YELLOW FERROSOFERRIC OXIDE HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED HYPROMELLOSE 2910 (15 MPA.S) HYPROMELLOSE 2910 (6 MPA.S) MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL 3350 POLYETHYLENE GLYCOL 400 POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC TALC TITANIUM DIOXIDE TRIETHYL CITRATE WATER LIGHT GREEN OPAQUE CAP WHITE OPAQUE BODY CAPSULE 1043

Application Number

ANDA208949

Brand Name

Topiramate

Generic Name

Topiramate

Product Ndc

70771-1659

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1656-3 Topiramate extended-release Capsules 25 mg Rx only 30 Capsules NDC 70771-1657-3 Topiramate extended-release Capsules 50 mg Rx only 30 Capsules NDC 70771-1658-3 Topiramate extended-release Capsules 100 mg Rx only 30 Capsules NDC 70771-1659-3 Topiramate extended-release Capsules 150 mg Rx only 30 Capsules NDC 70771-1660-3 Topiramate extended-release Capsules 200 mg Rx only 30 Capsules 25 mg label 50 mg label 100 mg label 150 mg label 200 mg label

Spl Medguide

SPL MEDGUIDE

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.